Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes.
Anticancer Agents Med Chem. 2022;22(7):1278-1285. doi: 10.2174/1871520621666210727112212.
Anticancer Agents Med Chem. 2022.
PMID: 34315390
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer.
Ghini V, Laera L, Fantechi B, Monte FD, Benelli M, McCartney A, Leonardo T, Luchinat C, Pozzessere D.
Ghini V, et al. Among authors: fantechi b.
Cancers (Basel). 2020 Nov 30;12(12):3574. doi: 10.3390/cancers12123574.
Cancers (Basel). 2020.
PMID: 33265926
Free PMC article.
Item in Clipboard
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation.
Lastraioli E, Antonuzzo L, Fantechi B, Di Cerbo L, Di Costanzo A, Lavacchi D, Armenio M, Arcangeli A, Castiglione F, Messerini L, Di Costanzo F.
Lastraioli E, et al. Among authors: fantechi b.
Oncol Lett. 2021 Jan;21(1):15. doi: 10.3892/ol.2020.12276. Epub 2020 Nov 6.
Oncol Lett. 2021.
PMID: 33240421
Free PMC article.
Item in Clipboard
Cite
Cite